Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Other 3Breast 2

Conditions

Obesity 3Breast Neoplasms 3Prostatic Neoplasms 2Overweight 2Melanoma 2Substance Withdrawal Syndrome 1Skin Neoplasms 1Metabolic Syndrome 1Kidney Neoplasms 1Inflammation 1Glioma 1Glioblastoma 1Dyslipidemias 1Chronic Pain 1Carcinoma, Lobular 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1

Interventions

Exercise 25Metformin 23Tirzepatide 9Resistance Training 8Nutrition Assessment 8Methods 8Diet Therapy 8Diet 8Counseling 8Surveys and Questionnaires 6Early Intervention, Educational 6Caloric Restriction 6semaglutide 5Liraglutide 5Exenatide 5Diet, Mediterranean 5Blood Specimen Collection 5Educational Status 4Docosahexaenoic Acids 4Bariatric Surgery 4exemestane 3Vitamin D 3Therapeutics 3Tamoxifen 3Sugars 3Standard of Care 3Observation 3Naltrexone 3Letrozole 3Dexamethasone 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Obesity × Naltrexone × Clear all
NCT05756764 2025-09-09

Anti-obesity Pharmacotherapy and Inflammation

Louisiana State University Health Sciences Center in New Orleans

Active not recruiting
30 enrolled
Other

Inflammation, Obesity, Metabolic Syndrome, Dyslipidemias

NCT04499950 2025-03-06

A-NEW

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed
53 enrolled 14 charts
BreastOther

Breast Neoplasms, Obesity, Overweight

NCT03581630 2018-08-29

Effects of Mediterranean Diet and Naltrexone/Bupropion Treatment in Obese Breast Cancer Patients

Gangnam Severance Hospital

Phase NA Completed
72 enrolled
BreastOther

Breast Neoplasms, Obesity, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡